6,7-Dimethoxyquinazoline-2,4(1H,3H)-dione

Lifitegrast Impurity 125

Pharmaceutical impurity reference standard

N-(5-((Diphenylphosphoryl)methyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide

Pharmaceutical intermediate

Tert-Butyl 2-((4R,6S)-6-((E)-2-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate

Rosuvastatin calcium intermediate

N-nitroso-tamsulosin

pharmaceutical reference standard

8-bromoquinazoline-2,4(1H,3H)-dione

research compound

6-Bromo-2,4(1H,3H)-quinazolinedione

Pharmaceutical intermediate compound

8-Chloro-6-fluoroquinazoline-2,4-diol

Pharmaceutical intermediate for quinazoline derivatives

7-Bromo-8-fluoro-6-(trifluoromethyl)quinazoline-2,4(1H,3H)-dione

Pharmaceutical intermediate